ORMAT TECHNOLOGIES, INC.
For the period ended Dec 31, 2025. Filed Feb 26, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 26, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
Index to Consolidated Financial Statements of Ormat Technologies, Inc. and Subsidiaries
| Report of Independent Registered Public Accounting Firm (PCAOB name: Kesselman & Kesselman C.P.A.s and PCAOB ID: 1309) | 99 |
|---|
| Consolidated Balance Sheets | 101 |
|---|---|
| Consolidated Statements of Operations and Comprehensive Income (Loss) | 103 |
| Consolidated Statements of Equity | 105 |
| Consolidated Statements of Cash Flows | 107 |
| Notes to Consolidated Financial Statements | 107 |
To the Board of Directors and Stockholders of Ormat Technologies, Inc.:
Opinions on the Financial Statements and Internal Control over Financial Reporting
We have audited the accompanying consolidated balance sheets of Ormat Technologies, Inc. and its subsidiaries (the “Company”) as of December 31, 2025 and 2024, and the related consolidated statements of operations and comprehensive income (loss), of equity and of cash flows for each of the three years in the period ended December 31, 2025 , including the related notes (collectively referred to as the “consolidated financial statements”). We also have audited the Company's internal control over financial reporting as of December 31, 2025, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).
In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2025 and 2024, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2025 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2025, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO.
Basis for Opinions
The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Management’s Report on Internal Control over Financial Reporting appearing under Item 9A. Our responsibility is to express opinions on the Company’s consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.
Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.
Definition and Limitations of Internal Control over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Critical Audit Matter
The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that (i) relates to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.
Estimates of Future Costs in Product Revenue Recognition
As described in Note 17 to the consolidated financial statements, $216.7 million of the Company's total revenues for the year ended December 31, 2025 was generated from product revenues, the majority of which related to long-term contracts. For the Company’s long-term contracts, control transfers over time and revenue is recognized based on the extent of progress in each period towards completion of the performance obligation. The selection of the measure of progress towards completion requires management judgment and is based on the nature of the products or services to be provided. As disclosed by management, the Company generally uses the percentage of completion method to measure progress for its contracts because management believes that measure best depicts the transfer of control to the customer, which occurs as the Company incurs costs related to those contracts. Under the percentage of completion method, the extent of progress towards completion is based on the ratio of costs incurred to date compared to the total estimated costs at completion of the performance obligation, which includes both the actual costs already incurred and the estimated costs to complete. Revenues are recognized proportionately as costs are incurred. Due to the nature of the work required to be performed on the performance obligation, management’s estimation of future costs to completion is complex and requires significant judgment. Management has disclosed that there are factors that can affect the accuracy of cost estimates, including, but not limited to, the ability to properly execute the engineering and design phases consistent with customer expectations, the availability and costs of labor and materials resources, and productivity.
The principal consideration for our determination that performing procedures relating to future costs to completion estimates in revenue recognition is a critical audit matter are that there was significant judgment by management when developing the estimates of future costs to complete projects. This in turn led to significant auditor judgment and effort in performing procedures to evaluate management's estimates of future costs to complete projects, including the assessment of management’s judgment about the Company’s ability to properly execute the engineering and design phases consistent with customer expectations and significant assumptions related to estimated expected labor costs.
Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to the revenue recognition process, including controls over the determination of estimates of future costs to complete projects. These procedures also included, among others, evaluating and testing management’s process for determining the estimates of future costs for a sample of projects. Evaluating the reasonableness of significant assumptions used involved evaluating management’s ability to estimate future costs to complete projects by (i) performing a comparison of the originally estimated and actual costs incurred on its projects; (ii) evaluating the timely identification of circumstances that warranted a modification to estimated costs to complete projects, including changes in job performance, job conditions, and estimated profitability; and (iii) testing management’s process for evaluating the Company’s ability to execute the specific contract characteristics.
| Tel-Aviv, Israel | Kesselman & Kesselman |
|---|---|
| February 26, 2026 | Certified Public Accountants (Isr.) |
| A member firm of PricewaterhouseCoopers International Limited |
We have served as the Company’s auditor since 2018.
| December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| (Dollars in thousands) | ||
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $147,448 | $94,395 |
| Restricted cash and cash equivalents (primarily related to VIEs) | 133,418 | 111,377 |
| Receivables: | ||
| Trade less allowance for credit losses of $308 and $224, respectively (primarily related to VIEs) | 164,772 | 164,050 |
| Other | 36,711 | 50,792 |
| Inventories | 45,268 | 38,092 |
| Costs and estimated earnings in excess of billings on uncompleted contracts | 30,011 | 29,243 |
| Prepaid expenses and other | 40,141 | 59,173 |
| Total current assets | 597,769 | 547,122 |
| Investment in unconsolidated companies | 162,111 | 144,585 |
| Deposits and other (primarily related to VIEs) | 137,744 | 75,383 |
| Deferred income taxes | 138,903 | 153,936 |
| Property, plant and equipment, net ($3,460,079 and $3,271,248 related to VIEs, respectively) | 3,672,569 | 3,501,886 |
| Construction-in-process ($392,644 and $251,442 related to VIEs, respectively) | 1,048,174 | 755,589 |
| Operating leases right of use ($17,236 and $13,989 related to VIEs, respectively) | 41,756 | 32,114 |
| Finance leases right of use (none related to VIEs) | 4,690 | 2,841 |
| Intangible assets, net | 274,548 | 301,745 |
| Goodwill | 168,244 | 151,023 |
| Total assets | $6,246,508 | $5,666,224 |
| LIABILITIES AND EQUITY | ||
| Current liabilities: | ||
| Accounts payable and accrued expenses | $234,757 | $234,334 |
| Short term revolving credit lines with banks (full recourse) | 80,000 | — |
| Commercial paper (less deferred financing costs of $17 and $23, respectively) | 99,983 | 99,977 |
| Billings in excess of costs and estimated earnings on uncompleted contracts | 13,159 | 23,091 |
| Current portion of long-term debt: | ||
| Limited and non-recourse (primarily related to VIEs): | 79,885 | 70,262 |
| Full recourse | 214,207 | 161,313 |
| Financing liability | 9,749 | 4,093 |
| Operating lease liabilities | 4,764 | 3,633 |
| Finance lease liabilities | 1,884 | 1,375 |
| Total current liabilities | 738,388 | 598,078 |
| Long-term debt, net of current portion: | ||
| Limited and non-recourse (primarily related to VIEs and less deferred financing costs of $13,488 and $8,849, respectively) | 645,803 | 578,204 |
| Full recourse (less deferred financing costs of $4,248 and $4,671, respectively) | 1,009,090 | 822,828 |
| Convertible senior notes (less deferred financing costs of $4,103 and $6,820, respectively) | 472,334 | 469,617 |
| Financing liability | 206,647 | 216,476 |
| Operating lease liabilities | 29,760 | 22,523 |
| Finance lease liabilities | 2,850 | 1,529 |
| Liability associated with sale of tax benefits | 190,168 | 152,292 |
| Deferred income taxes | 68,661 | 68,616 |
|---|---|---|
| Liability for unrecognized tax benefits | 10,378 | 6,272 |
| Liabilities for severance pay | 11,942 | 10,488 |
| Asset retirement obligation | 135,574 | 129,651 |
| Other long-term liabilities | 33,637 | 29,270 |
| Total liabilities | $3,555,232 | $3,105,844 |
| Commitments and contingencies (Note 20) | ||
| Redeemable noncontrolling interest | 10,402 | 9,448 |
| Equity: | ||
| The Company's stockholders' equity: | ||
| Common stock, par value $0.001 per share; 200,000,000 shares authorized; 60,845,411 and 60,500,580 issued and outstanding as of December 31, 2025 and December 31, 2024, respectively | 61 | 61 |
| Additional paid-in capital | 1,654,635 | 1,635,245 |
| Treasury stock, at cost (258,667 shares held as of December 31, 2025 and 2024, respectively) | (17,964) | (17,964) |
| Retained earnings | 909,343 | 814,518 |
| Accumulated other comprehensive loss | (2,132) | (6,731) |
| Total stockholders' equity attributable to Company's stockholders | 2,543,943 | 2,425,129 |
| Noncontrolling interest | 136,931 | 125,803 |
| Total equity | 2,680,874 | 2,550,932 |
| Total liabilities, redeemable noncontrolling interest and equity | $6,246,508 | $5,666,224 |
The accompanying notes are an integral part of the consolidated financial statements.
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
| Year Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| (Dollars in thousands, except earnings per share data) | |||
| Revenues: | |||
| Electricity | $693,900 | $702,264 | $666,767 |
| Product | 216,686 | 139,661 | 133,763 |
| Energy storage | 78,957 | 37,729 | 28,894 |
| Total revenues | 989,543 | 879,654 | 829,424 |
| Cost of revenues: | |||
| Electricity | 495,989 | 459,526 | 422,549 |
| Product | 170,671 | 113,911 | 115,802 |
| Energy storage | 50,198 | 33,598 | 27,055 |
| Total cost of revenues | 716,858 | 607,035 | 565,406 |
| Gross profit | 272,685 | 272,619 | 264,018 |
| Operating expenses: | |||
| Research and development expenses | 6,304 | 6,501 | 7,215 |
| Selling and marketing expenses | 18,898 | 17,694 | 18,306 |
| General and administrative expenses | 79,592 | 80,119 | 68,179 |
| Other operating income | (14,844) | (9,375) | — |
| Impairment of long-lived assets | 12,064 | 1,280 | — |
| Write-off of unsuccessful exploration and storage activities | 1,446 | 3,930 | 3,733 |
| Operating income | 169,225 | 172,470 | 166,585 |
| Other income (expense): | |||
| Interest income | 6,015 | 7,883 | 11,983 |
| Interest expense, net | (141,851) | (134,031) | (98,881) |
| Derivatives and foreign currency transaction gains (losses) | 5,248 | (4,187) | (3,278) |
| Income attributable to sale of tax benefits | 66,726 | 73,054 | 61,157 |
| Other non-operating income, net | 385 | 188 | 1,519 |
| Income from operations before income tax and equity in earnings (losses) of investees | 105,748 | 115,377 | 139,085 |
| Income tax (provision) benefit | 20,282 | 16,289 | (5,983) |
| Equity in earnings (losses) of investees | 960 | (425) | 35 |
| Net income | 126,990 | 131,241 | 133,137 |
| Net income attributable to noncontrolling interest | (3,092) | (7,508) | (8,738) |
| Net income attributable to the Company's stockholders | 123,898 | $123,733 | $124,399 |
| Comprehensive income: | |||
| Net income | 126,990 | 131,241 | 133,137 |
| Other comprehensive income (loss), net of related taxes: | |||
| Change in foreign currency translation adjustments | 9,665 | (8,232) | 1,257 |
| Change in unrealized gains or (losses) in respect of the Company's share in derivatives instruments of unconsolidated investment that qualifies as a cash flow hedge | (1,230) | 602 | (470) |
| Change in unrealized gains or losses in respect of a cross-currency swap derivative instrument that qualifies as a cash flow hedge (net of related tax of $68, $324 and $1,511, respectively) | (1,780) | 988 | (4,237) |
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
| Change in unrealized gains or losses in respect of an interest rate swap derivative instrument that qualifies as a cash flow hedge (net of related tax of $0 for all periods presented) | 113 | 13 | — | ||
|---|---|---|---|---|---|
| Other changes in comprehensive income | 45 | 50 | 53 | ||
| Comprehensive income | $133,803 | 124,662 | 129,740 | ||
| Comprehensive income attributable to noncontrolling interest | (5,306) | (6,328) | (9,173) | ||
| Comprehensive income attributable to the Company's stockholders | $128,497 | $118,334 | $120,567 | ||
| Earnings per share attributable to the Company's stockholders: | |||||
| Basic: | $2.04 | $2.05 | $2.09 | ||
| Diluted: | $2.02 | $2.04 | $2.08 | ||
| Weighted average number of shares used in computation of earnings per share attributable to the Company's stockholders: | |||||
| Basic | 60,705 | 60,455 | 59,424 | ||
| Diluted | 61,362 | 60,790 | 59,762 | ||
The accompanying notes are an integral part of the consolidated financial statements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.